0001493152-24-008916.txt : 20240305 0001493152-24-008916.hdr.sgml : 20240305 20240305200030 ACCESSION NUMBER: 0001493152-24-008916 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230822 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Ann CENTRAL INDEX KEY: 0001953080 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 24723785 MAIL ADDRESS: STREET 1: C/O COYA THERAPEUTICS, INC. STREET 2: 5850 SAN FELIPE ST., SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml X0508 4 2023-08-22 0 0001835022 Coya Therapeutics, Inc. COYA 0001953080 Lee Ann 5850 SAN FELIPE ST., SUITE 500 HOUSTON TX 77057 1 0 0 0 0 Common Stock, par value $0.0001 per share 2023-08-22 4 P 0 1000 3.62 A 17479 I By Spouse IRA Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request. /s/ David Snyder, Attorney-in-Fact 2024-03-05